Mid-cap Health Care company Elanco Animal Health has logged a -0.9% change today on a trading volume of 3,780,183. The average volume for the stock is 5,513,423.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. Based in Greenfield, United States the company has 9,000 full time employees and a market cap of $6,726,692,864.
The company is now trading -0.73% away from its average analyst target price of $13.75 per share. The 8 analysts following the stock have set target prices ranging from $10.0 to $18.0, and on average give Elanco Animal Health a rating of hold.
Over the last 52 weeks, ELAN stock has risen 14.6%, which amounts to a -8.0% difference compared to the S&P 500. The stock's 52 week high is $14.69 whereas its 52 week low is $7.88 per share. With its net margins declining an average -11.7% over the last 6 years, Elanco Animal Health may not have a strong enough profitability trend to support its stock price.
Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
---|---|---|---|---|
2023 | 4,411,000 | -1,144,000 | -26 | -1200.0 |
2022 | 4,411,000 | -78,000 | -2 | 80.0 |
2021 | 4,764,000 | -483,000 | -10 | 44.44 |
2020 | 3,271,000 | -574,000 | -18 | -1000.0 |
2019 | 3,071,000 | 68,000 | 2 | -33.33 |
2018 | 3,066,800 | 86,500 | 3 |